Dr Mireia Crispin is an Assistant Professor in the Department of Oncology of the University of Cambridge and Group Leader at the Early Cancer Institute. Her research group focuses on the development of radiogenomic data integration models to understand and predict the evolution of hard-to-treat cancers. She co-leads the Ovarian Programme at the CRUK Cancer Centre, and the Mark Foundation Institute for Integrated Cancer Medicine. She is also the Chief Digital Officer of 52 North Health, an award-winning biotech start-up developing affordable at-home tests for cancer patients. Dr Crispin worked previously at Memorial Sloan Kettering Cancer Center in New York, and was the Director of the Healthcare Innovation programme of the Center for the Governance of Change at IE University (Madrid, Spain), focusing on policy challenges for the integration of AI and digital health in European healthcare. She holds a PhD in Particle Physics (University of Oxford, 2015). She is an author in over 400 publications and has received numerous national and international awards, most recently finalist of the Cancer Research Horizons Early-Career Entrepreneur of the Year 2022 award.

Evis Sala is the Professor of Oncological Imaging at the University of Cambridge, United Kingdom (UK) and co-leads the Cancer Research UK Cambridge Centre Advanced Cancer Imaging Programme and the Integrated Cancer Medicine Programme. Dr Sala’s research focuses on the development and validation of functional imaging biomarkers to rapidly evaluate treatment response using physiologic and metabolic tumour habitat imaging. Her research in radiogenomics has focused on understanding the molecular basis of cancer by demonstrating the phenotypic patterns that occur as a result of multiple genetic alterations that interact with the tumour microenvironment to drive the disease in several tumour types. Her work integrates quantitative imaging methods for evaluation spatial and temporal tumour heterogeneity with genomics, proteomics and metabolomics. She is also leading multiple research projects focusing on developing and implementing artificial intelligence methods for image reconstruction, segmentation, and data integration. Dr Sala is an outstanding educator, orator and mentor. In recognition for her contribution to education and research in oncological imaging, she received the Radiology Society of North America (RSNA) Honoured Educator Award in 2014, 2017 and 2020. Her leadership extends to the most important international bodies in the field, as Fellow of the International Cancer Imaging Society, Fellow of the International Society for Magnetic Resonance in Medicine and Fellow of the European Society of Urogenital Radiology. 

Dr Ramona Woitek is a Senior Research Associate and Honorary Consultant Radiologist in the Department of Radiology of the University of Cambridge. Her research focuses on breast and ovarian cancer, with a special focus on new imaging techniques and image analysis for the early detection of treatment response. Ramona did her undergraduate studies, PhD and Radiology training at the Medical University of Vienna, Austria, and joined the University of Cambridge in 2017.